These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 13319011)

  • 1. Effect of bishydroxycoumarin (dicumarol) on clotting time of whole blood.
    MAYER GA; CONNELL WF
    J Am Med Assoc; 1956 Jun; 161(9):806-11. PubMed ID: 13319011
    [No Abstract]   [Full Text] [Related]  

  • 2. The comparative action of dicumarol and of phenylindanedione on the coagulase reacting factor and on prothrombin.
    TAGER M
    Yale J Biol Med; 1953 Apr; 25(5):374-82. PubMed ID: 13057268
    [No Abstract]   [Full Text] [Related]  

  • 3. [Control of dicoumarin effect on blood coagulation].
    THIES HA
    Langenbecks Arch Klin Chir Ver Dtsch Z Chir; 1952-1953; 273():320-2. PubMed ID: 13045631
    [No Abstract]   [Full Text] [Related]  

  • 4. Studies on the efficiency of vitamin K1 in small doses as antidote against anticoagulants of the dicoumarol type.
    GEILL T; LUND E; DAM H; SØNDERGAARD E
    Scand J Clin Lab Invest; 1954; 6(3):203-9. PubMed ID: 13205146
    [No Abstract]   [Full Text] [Related]  

  • 5. The influence of ACTH on prothrombin-proconvertin values in blood during treatment with dicumarol and phenylindanedione.
    HELLEM AJ; SOLEM JH
    Acta Med Scand; 1954; 150(5):389-93. PubMed ID: 13217736
    [No Abstract]   [Full Text] [Related]  

  • 6. Control of dicumarol therapy by means of a micromethod for the quantitative determination of plasma prothrombin and proconvertin.
    LUND E; DYGGVE H
    Acta Med Scand; 1954; 150(4):271-5. PubMed ID: 13217722
    [No Abstract]   [Full Text] [Related]  

  • 7. Effect of dicumarol on bleeding time.
    VAN CAUWENBERGE H; JAQUES LB
    Proc Soc Exp Biol Med; 1958 Jul; 98(3):599-602. PubMed ID: 13567784
    [No Abstract]   [Full Text] [Related]  

  • 8. The effect of splenectomy on the action of dicumarol; an experimental study, with case report.
    POSTHUMA AE
    Med Bull (Ann Arbor); 1953 Mar; 19(3):62-9. PubMed ID: 13049720
    [No Abstract]   [Full Text] [Related]  

  • 9. The control of prothrombin activity with tromexan therapy.
    WEINER M; SIMSON G; BURNS JJ; STEELE JM; BRODIE BB
    Am J Med; 1953 Jun; 14(6):689-93. PubMed ID: 13057878
    [No Abstract]   [Full Text] [Related]  

  • 10. [Effects on mother and infant of dicumarol therapy in pregnancy].
    VAN ASSEN FJ; KOOY HJ
    Ned Tijdschr Geneeskd; 1955 Jan; 99(2):107-11. PubMed ID: 14356260
    [No Abstract]   [Full Text] [Related]  

  • 11. The control of dicumarol therapy in myocardial infarction by a simple blood prothrombin test.
    MANCHESTER B; RABKIN B
    Circulation; 1954 Nov; 10(5):691-8. PubMed ID: 13209750
    [No Abstract]   [Full Text] [Related]  

  • 12. Dicumarol and plasma antithrombin activity.
    IVANOVIC N; JOHNSON JF; OLWIN JH; SEEGERS WH
    Proc Soc Exp Biol Med; 1954 Mar; 85(3):496-500. PubMed ID: 13167118
    [No Abstract]   [Full Text] [Related]  

  • 13. [Effect of heparin on percentage content of prothrombin; range of variations and their significance in relation to heparin with dicumarol therapy].
    TAGLIACOZZO S
    Policlinico Chir; 1956; 63(3):141-59. PubMed ID: 13349502
    [No Abstract]   [Full Text] [Related]  

  • 14. [Action of lability factor on the effects of sodium salicylate and tromexan on prothrombin time].
    SERT AS
    Tip Fak Mecm; 1954; 17(3):434-9. PubMed ID: 13226361
    [No Abstract]   [Full Text] [Related]  

  • 15. Behaviour of factors II, VII, IX and X during long-term treatment with coumarin.
    LOELIGER EA; van der ESCH ; MATTERN MJ; den BRABANDER AS
    Thromb Diath Haemorrh; 1963 Apr; 9():74-89. PubMed ID: 13931274
    [No Abstract]   [Full Text] [Related]  

  • 16. [Variations in fibrinogenemia, prothrombin time and liquoid coagulation time during treatment with anticoagulants].
    FRANCESCON M; BUTTO M
    Acta Med Patav; 1952; 13(6):265-88. PubMed ID: 13039951
    [No Abstract]   [Full Text] [Related]  

  • 17. Bishydroxycoumarin (dicumarol) therapy in myocardial infarction; results of bishydroxycoumarin therapy as it is practiced in a private hospital.
    FELDMAN L; SCHAEFER GL; GOLDSTEIN SE; FORMAN IM
    AMA Arch Intern Med; 1954 Sep; 94(3):433-7. PubMed ID: 13196725
    [No Abstract]   [Full Text] [Related]  

  • 18. Over-all coagulability in patients receiving dicumarol therapy with emphasis on acute myocardial infarction.
    ROSENTHAL RL
    J Lab Clin Med; 1956 Apr; 47(4):611-22. PubMed ID: 13307096
    [No Abstract]   [Full Text] [Related]  

  • 19. AN INVESTIGATION OF THE HEMORRHAGIC DIATHESIS IN PATIENTS RECEIVING COUMARIN AND INDANEDIONE ANTICOAGULANTS.
    BAUGH CW
    Can Med Assoc J; 1965 Jan; 92(3):116-20. PubMed ID: 14232183
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The regulation of dicumarol dosage by special venous clotting technics.
    MACRAE LD
    Am Pract Dig Treat; 1956 Jan; 7(1):38-43. PubMed ID: 13275654
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.